Haemonetics Corporation (HAE)
NYSE: HAE · Real-Time Price · USD
53.88
0.00 (0.00%)
Aug 13, 2025, 4:00 PM - Market open
Haemonetics Income Statement
Financials in millions USD. Fiscal year is April - March.
Millions USD. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 28, 2025 | Mar '25 Mar 29, 2025 | Mar '24 Mar 30, 2024 | Apr '23 Apr 1, 2023 | Apr '22 Apr 2, 2022 | Apr '21 Apr 3, 2021 | 2016 - 2020 |
| Revenue | 1,346 | 1,361 | 1,309 | 1,169 | 993.2 | 870.46 | Upgrade
|
| Revenue Growth (YoY) | 0.91% | 3.96% | 12.01% | 17.67% | 14.10% | -11.94% | Upgrade
|
| Cost of Revenue | 554.93 | 582.28 | 597.14 | 545.79 | 462.43 | 442.02 | Upgrade
|
| Gross Profit | 791.12 | 778.55 | 711.92 | 622.87 | 530.77 | 428.45 | Upgrade
|
| Selling, General & Admin | 420.62 | 422.05 | 420.82 | 373.95 | 332.2 | 263.83 | Upgrade
|
| Research & Development | 62.25 | 61.13 | 52.23 | 49.08 | 45.98 | 31.69 | Upgrade
|
| Operating Expenses | 530.06 | 531.45 | 505.08 | 455.67 | 425.6 | 328.35 | Upgrade
|
| Operating Income | 261.06 | 247.1 | 206.84 | 167.2 | 105.17 | 100.1 | Upgrade
|
| Interest Expense | -39.97 | -35.9 | -19.5 | -13 | -5.8 | -9.4 | Upgrade
|
| Currency Exchange Gain (Loss) | -6.17 | -1.53 | - | - | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | 8.13 | 15.09 | 6.48 | -1.63 | -11.32 | -4.43 | Upgrade
|
| EBT Excluding Unusual Items | 223.05 | 224.75 | 193.82 | 152.57 | 88.05 | 86.26 | Upgrade
|
| Merger & Restructuring Charges | -45.76 | -45.91 | -33.54 | -11.55 | -28.82 | -25.26 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | 2 | 0.38 | 9.6 | 32.81 | Upgrade
|
| Asset Writedown | -2.39 | -2.39 | -10.42 | - | -5.2 | -20.9 | Upgrade
|
| Other Unusual Items | 35.62 | 35.62 | - | - | - | - | Upgrade
|
| Pretax Income | 210.53 | 212.07 | 151.87 | 141.4 | 63.63 | 72.91 | Upgrade
|
| Income Tax Expense | 47.19 | 44.39 | 34.31 | 26 | 20.25 | -6.56 | Upgrade
|
| Net Income | 163.34 | 167.68 | 117.56 | 115.4 | 43.38 | 79.47 | Upgrade
|
| Net Income to Common | 163.34 | 167.68 | 117.56 | 115.4 | 43.38 | 79.47 | Upgrade
|
| Net Income Growth | 42.17% | 42.63% | 1.87% | 166.05% | -45.42% | 3.85% | Upgrade
|
| Shares Outstanding (Basic) | 50 | 50 | 51 | 51 | 51 | 51 | Upgrade
|
| Shares Outstanding (Diluted) | 50 | 51 | 51 | 51 | 51 | 51 | Upgrade
|
| Shares Change (YoY) | -2.96% | -1.30% | -0.04% | 0.13% | 0.12% | -1.01% | Upgrade
|
| EPS (Basic) | 3.29 | 3.33 | 2.32 | 2.27 | 0.85 | 1.57 | Upgrade
|
| EPS (Diluted) | 3.28 | 3.31 | 2.29 | 2.24 | 0.84 | 1.55 | Upgrade
|
| EPS Growth | 46.89% | 44.54% | 2.23% | 166.67% | -45.81% | 4.73% | Upgrade
|
| Free Cash Flow | 189.17 | 142.45 | 143.63 | 81.73 | 75.75 | 71.77 | Upgrade
|
| Free Cash Flow Per Share | 3.79 | 2.81 | 2.79 | 1.59 | 1.48 | 1.40 | Upgrade
|
| Gross Margin | 58.77% | 57.21% | 54.38% | 53.30% | 53.44% | 49.22% | Upgrade
|
| Operating Margin | 19.39% | 18.16% | 15.80% | 14.31% | 10.59% | 11.50% | Upgrade
|
| Profit Margin | 12.13% | 12.32% | 8.98% | 9.88% | 4.37% | 9.13% | Upgrade
|
| Free Cash Flow Margin | 14.05% | 10.47% | 10.97% | 6.99% | 7.63% | 8.24% | Upgrade
|
| EBITDA | 369.57 | 355.99 | 295.45 | 252.01 | 191.72 | 184.38 | Upgrade
|
| EBITDA Margin | 27.46% | 26.16% | 22.57% | 21.56% | 19.30% | 21.18% | Upgrade
|
| D&A For EBITDA | 108.51 | 108.89 | 88.62 | 84.81 | 86.55 | 84.29 | Upgrade
|
| EBIT | 261.06 | 247.1 | 206.84 | 167.2 | 105.17 | 100.1 | Upgrade
|
| EBIT Margin | 19.39% | 18.16% | 15.80% | 14.31% | 10.59% | 11.50% | Upgrade
|
| Effective Tax Rate | 22.41% | 20.93% | 22.59% | 18.39% | 31.83% | - | Upgrade
|
| Advertising Expenses | - | 7.7 | 7.1 | 7.2 | 4.4 | 2.7 | Upgrade
|
Updated Aug 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.